In a phase 3 trial, the agent reduces seizure frequency by up to 53% in treatment-resistant focal epilepsy, with rapid onset ...
Ego Pharmaceuticals improved assay efficiency, reduced solvent use, and enhanced UV/Vis precision through automated ...
Xenon Pharmaceuticals Inc.’s bull case improved after X-TOLE2 showed robust focal seizure reduction in a highly refractory ...
A study in Nature found a specific genetic variant that may boost the effectiveness of GLP-1 weight-loss drugs like ...
The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...
Discover the top 10 weight loss medications of 2026. Explore how advanced GLP-1 therapies and combination drugs are reshaping ...
MedPage Today on MSN
Navy Recruits Doctors by Appealing to Administrative Frustrations
Ad campaign has popped up in four major cities ...
CHICAGO, April 20, 2026 /PRNewswire/ -- Experts from NYU Langone Health's Department of Neurology present their latest clinical findings and research discoveries at the American Academy of Neurology ...
SnoreRX examines its FDA-cleared mandibular advancement mouthpiece design, 1-millimeter adjustable calibration, boil-and-bite ...
Unicycive Therapeutics, Inc. (UNCY) 25th Annual Needham Virtual Healthcare Conference April 15, 2026 3:45 PM EDTCompany ParticipantsShalabh Gupta - ...
Even though India prohibits direct-to-consumer marketing of prescription drugs, regulators are watching out for messaging to ...
Explore Suffolk health checks and the shift in school gate conversations towards proactive health management and wellness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results